GastroPlus enables innovators across the drug lifecycle to confidently explore and gain critical understanding, transforming complex questions into data-driven, regulatory-ready insights.
With GastroPlus, you can:
- Make predictions from structure to drive chemistry and prioritize experiments
- Conduct preclinical verification and translation to human in a single integrated platform
- Define first-in-human (FIH) dose strategies grounded in mechanistic science
- Anticipate food effects and optimize formulation strategies before costly studies
- Quantify drug-drug interaction risk with defensible regulatory justification
- Support biowaivers and reduce unnecessary clinical burden
- Conduct virtual bioequivalence and population simulations to de-risk programs